跳到主要内容
搜索

Clinical Development Head - BioPharma

地点 北京, 北京, 中国 上海, 上海, 中国 职位 ID R-230586 发布日期 07/07/2025

Biopharma Clinical Development Head is a SET-2 role and take the overall accountability to the Head of R&D China for biopharma portfolio delivery and safety science in China, including development of scientific strategy, creation and implementation of Clinical Development Plans of Biopharmaceutical therapeutic area. The role is an important interface representing R&D China with internal and external stakeholders in the responsible TA. The role also has line management responsibility for development physicians/scientists in Biopharmaceutical TA. This role will also serve as the co-chair of Project Review Forum of biopharma TA and member of China Portfolio Management Committee.

Typical Accountabilities

  • Lead to develop China Biopharma drug development strategy, and contribute to R&D China scientific strategy
  • Responsible for planning and execution of all biopharma portfolio projects, serve as a member of China portfolio management committee (PMC) for biopharma TA decision making
  • Accountable for the successful delivery of biopharma portfolio, co-chair China Biopharma Project Review Form to ensure the quality and speedy delivery
  • Owner of development documents (CIB, protocol and CSR, ETC) with China content
  • Oversight of Safety and PK/PD programs at portfolio level to support the portfolio project delivery
  • Oversee TA clinical science, Translational medicine and Safe science functions, drive the performance for project delivery and any other initiatives
  • Build and develop a strong Biopharma clinical development team, foster a life-learning culture, coaching culture, develop physicians’ capability, and support their career development
  • Build and develop strong CNPT (China Product Team) in biopharma TA
  • Lead to ensure effective collaboration with global biopharma clinical development teams, to foster knowledge sharing, global projects deliver and talent exchange
  • Build and strengthen the alliance with key external partners including the academia institutes, and KOLs

Education, Qualifications, Skills and Experience

Essential

Academic / Professional Qualification

  • Medical Doctor Degree
  • Global drug development experience

Technical / Skills Training

  • Deep biopharma therapeutic area knowledge
  • Sufficient regulatory knowledge for BioPharma TA and necessary Statistics knowledge
  • Insight on biopharma research and development in China
  • Broad network with Chinese KOLs and investigators
  • Deep knowledge of CSP/CSR development and study data interpretation
  • Excellent in communication and presentation, both in English and Chinese
  • Strategic thinking and prioritization
  • Strong problem solving and analytical skills
  • Strong leadership in building effective teams, developing talents, etc
  • Ability in fostering collaboration, life learning, inclusion & diversity cultures

Working Experience

  • Minimum 10 years clinical development experience in pharmaceutical companies
  • Minimum 5 years on biopharma TA leader role (>= Director level position) with successful delivery track record of drug development and registration
  • Rich NDA submission experience
  • Rich Medical monitoring experience

Desirable

  • Experience in regulatory agency interaction
  • Philosophy Doctor degree


AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.

Glassdoor logo Rated four stars on Glassdoor

优秀的文化,出色的工作任务,充满支持的管理模式。 公司内部的轮换机会。 他们重视包容性和多样性。